-logo.jpg "AllStripes (now PicnicHealth)"){kind=logo}
San Francisco, United States
AllStripes (now PicnicHealth) was a pioneering healthcare technology company founded in 2017 in the United States. With the slogan "Unlocking new treatments for people with rare disease," it uniquely positioned itself in the intersection of Big Data, Biotechnology, Health Care, and Marketing.
The company's innovative approach involved bridging the gap between the biopharmaceutical industry and families affected by rare diseases. By identifying "needle-in-a-haystack" patients, obtaining comprehensive medical records, and structuring clinical data for FDA-grade applications, AllStripes enabled research that was both patient-centered and transformative.
Before its acquisition by PicnicHealth in 2023, AllStripes raised $67 million in total funding, with a significant $50 million Series B investment led by investors such as Maveron, Lux Capital, and Spark Capital on August 24, 2021. The company collaborated with industry giants like Novartis and UCB, showcasing its capability to offer deeper insights into the rare disease landscape.
